Aurora Cannabis (ACB) Competitors $4.64 0.00 (0.00%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. WVE, ETNB, COLL, MLYS, NTLA, SYRE, ZYME, RCUS, NRIX, and CMRXShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Wave Life Sciences (WVE), 89bio (ETNB), Collegium Pharmaceutical (COLL), Mineralys Therapeutics (MLYS), Intellia Therapeutics (NTLA), Spyre Therapeutics (SYRE), Zymeworks (ZYME), Arcus Biosciences (RCUS), Nurix Therapeutics (NRIX), and Chimerix (CMRX). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Wave Life Sciences 89bio Collegium Pharmaceutical Mineralys Therapeutics Intellia Therapeutics Spyre Therapeutics Zymeworks Arcus Biosciences Nurix Therapeutics Chimerix Wave Life Sciences (NASDAQ:WVE) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership. Does the media favor WVE or ACB? In the previous week, Wave Life Sciences had 6 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Wave Life Sciences and 4 mentions for Aurora Cannabis. Wave Life Sciences' average media sentiment score of 1.08 beat Aurora Cannabis' score of 0.60 indicating that Wave Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor WVE or ACB? Aurora Cannabis received 16 more outperform votes than Wave Life Sciences when rated by MarketBeat users. However, 67.90% of users gave Wave Life Sciences an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36867.90% Underperform Votes17432.10% Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Do institutionals and insiders hold more shares of WVE or ACB? 89.7% of Wave Life Sciences shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is WVE or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Wave Life Sciences' net margin of -66.50%. Aurora Cannabis' return on equity of 0.59% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Aurora Cannabis 0.42%0.59%0.42% Do analysts recommend WVE or ACB? Wave Life Sciences currently has a consensus price target of $21.17, suggesting a potential upside of 174.18%. Given Wave Life Sciences' higher probable upside, analysts clearly believe Wave Life Sciences is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has better earnings and valuation, WVE or ACB? Aurora Cannabis has higher revenue and earnings than Wave Life Sciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$108.30M10.94-$57.51M-$0.79-9.77Aurora Cannabis$320.81M0.81-$48.62M$0.0592.80 Which has more risk & volatility, WVE or ACB? Wave Life Sciences has a beta of -0.93, indicating that its share price is 193% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500. SummaryAurora Cannabis beats Wave Life Sciences on 11 of the 19 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$260.83M$1.19B$5.56B$7.83BDividend YieldN/AN/A5.11%4.22%P/E Ratio92.8210.4522.4418.48Price / Sales0.8110.33393.95103.59Price / Cash26.3510.4038.1834.62Price / Book0.571.456.774.25Net Income-$48.62M-$54.34M$3.22B$248.23M7 Day Performance-1.49%4.05%1.45%0.89%1 Month Performance6.18%24.15%3.96%3.53%1 Year Performance-36.96%-37.14%16.07%5.08% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.6453 of 5 stars$4.64flatN/A-49.7%$260.83M$320.81M92.821,340News CoverageWVEWave Life Sciences4.313 of 5 stars$6.12+3.4%$22.18+262.4%+56.6%$939.33M$108.30M-5.51240Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsETNB89bio2.7852 of 5 stars$6.27+3.5%$27.56+339.5%-5.8%$915.32MN/A-2.1540Upcoming EarningsPositive NewsCOLLCollegium Pharmaceutical4.051 of 5 stars$26.91-0.4%$43.60+62.0%-26.9%$864.67M$631.45M11.60210Upcoming EarningsPositive NewsMLYSMineralys Therapeutics2.3896 of 5 stars$13.24-0.8%$33.00+149.2%+16.0%$858.96MN/A-3.6428Upcoming EarningsShort Interest ↑NTLAIntellia Therapeutics4.4678 of 5 stars$7.92+9.5%$36.68+363.2%-58.6%$819.86M$57.88M-1.46600Upcoming EarningsPositive NewsHigh Trading VolumeSYRESpyre Therapeutics1.7938 of 5 stars$13.57+7.1%$49.57+265.3%-53.9%$817.95M$890,000.00-1.82100Upcoming EarningsPositive NewsZYMEZymeworks2.7711 of 5 stars$11.75+1.9%$21.00+78.7%+51.6%$817.53M$76.30M-7.83460Upcoming EarningsPositive NewsRCUSArcus Biosciences2.0487 of 5 stars$7.68-2.5%$30.25+293.9%-42.6%$807.46M$258M-2.44500Upcoming EarningsPositive NewsGap DownNRIXNurix Therapeutics1.9428 of 5 stars$10.55+3.0%$30.44+188.6%-4.1%$804.29M$56.42M-3.65300Analyst ForecastPositive NewsGap DownCMRXChimerix3.0303 of 5 stars$8.55-0.1%$8.53-0.1%N/A$801.56M$212,000.00-9.0990 Related Companies and Tools Related Companies Wave Life Sciences Competitors 89bio Competitors Collegium Pharmaceutical Competitors Mineralys Therapeutics Competitors Intellia Therapeutics Competitors Spyre Therapeutics Competitors Zymeworks Competitors Arcus Biosciences Competitors Nurix Therapeutics Competitors Chimerix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts